December 23, 2010

The Food and Drug Administration has approved the first and only low-dose oral contraceptive to combine 0.8-mg norethindrone and 0.025-mg ethinyl estradiol in a chewable form, with four 75-mg ferrous fumarate (iron) placebo tablets, Watson Pharmaceuticals has announced.

June 15, 2010

Two drug makers will work together to develop a drug for the treatment of endometriosis,...

March 3, 2010

Watson Pharmaceuticals will buy the U.S. rights to two progesterone products used to treat infertility...